The mechanism may include three aspects: (1) the BRAFV600E mutation leads to sustained activation of the RAS-RAF-MEK-ERK/MAPK pathway, enhancing cell mitotic capacity, ultimately leading to abnormal cell proliferation, and inducing tumor occurrence [10]. Here, MAP2K7 is linked to neoplasm.